bioRxiv Science⌕ Search

bioRxiv · 10.1101/2023.05.20.541565

Cancer initiation is influenced by sex-biased tissue environment or imbalanced hormones

Abstract

There is extensive evidence of sex differences in the susceptibility and prognosis of non-reproductive cancers. In addition to external factors, biological sex bias (e.g., sex chromosomes, hormones, and immune function) is suspected to function as a selective pressure that influences the evolutionary process of carcinogenesis. However, there remains a lack of clarity concerning the extent of the effect of sex bias on carcinogenesis, as well as the underlying mechanism. In this study, we show that tissue sex bias, correlated to gonadotropin-releasing hormone, varies among tissues and is associated with two distinct age-specific patterns of cancer incidence: parallel and nonparallel. Additionally, we reveal that imbalances in estrogen receptor alpha and thyroid hormone receptors are associated with levels of hypoxia-inducible factors, which have three phases (hypoxia, hyperoxia, and "chaotic-oxia") that exist in most cancers and are linked to specific cancer subtypes, including cancers with microsatellites, the CpG island methylator phenotype, or hypermethylation. Our results suggest that sex-biased tissue environments and hormonal imbalances may influence the incidence pattern and direction of carcinogenesis, emphasizing the importance of maintaining hormonal homeostasis for cancer prevention and providing insights toward improving therapies for cancer types with hormonal imbalances. Plain English summarySex bias has been long observed in cancer susceptibility and prognosis. Hormone difference between the two sexes was believed to play a role. However, the mechanism is still largely unknown. Our study has shown that the activity of one hormone secreted from pituitary, namely gonadotropin-releasing hormone, are correlated to sex-biased tissue environment, which was speculated to influence incidence patterns of carcinogenesis. Furthermore, hormonal imbalance, particularly imbalance in receptors of estrogen and thyroid hormone, which is associated with specific cancer subtypes, was speculated to influence the direction of carcinogenesis. HighlightsO_LIThere are two distinct patterns of cancer age-specific incidence curve between the two sexes: parallel and nonparallel. C_LIO_LIThe parallel and nonparallel patterns are associated with sex bias in tissue environments which is correlated with sex-biased activity of gonadotropin-releasing hormone. C_LIO_LIThree sex-biased mutated genes: PTEN, PGM5 and LARP4B, have tissue-specific hotspot mutations which are associated with microsatellite instability (MSI), and the proportion of MSI exhibit sex bias in stomach cancer. C_LIO_LIThree hypoxia induce factors (HIFs) phases: hypoxia, hyperoxia, and "chaotic-oxia", exist in most cancers and are linked to specific cancer subtypes, including cancers with MSI, the CpG island methylator phenotype, and hypermethylation. C_LIO_LIThe phases of HIFs are associated with imbalances between estrogen receptor alpha and thyroid hormone receptors. C_LI

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Zhang, F., Deng, M.. 2023-05-22. Cancer initiation is influenced by sex-biased tissue environment or imbalanced hormones. https://doi.org/10.1101/2023.05.20.541565

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Epigenetic progression of pancreatic cancer to aggressive subtypes involves alternate routes of lineage reprogramming in subtype-intermediate progenitor cells

Pancreatic ductal adenocarcinoma (PDAC) progression involves malignant cell state plasticity. Epigenetic changes underlie this plasticity, yet the PDAC cis-regulatory landscape remains understudied. To address this, we profiled 33 primary tumors and 7 metastases from 39 patients with single-cell ATAC-seq, paired with 10 single-cell RNA-seq profiles. We found that epigenetic GATA6+/KRT17+ co-accessibility identifies a classical-basal subtype-intermediate progenitor state (SIP) associated with better clinical outcomes. SIP cells display limited epigenetic reprogramming from premalignant epithelium and retain gastric-intestinal differentiation reminiscent of neoplastic precursors. Lineages without GATA6+/KRT17+ co-accessibility exhibit greater lineage and epithelial-mesenchymal plasticity. Classical PDACs that repress basal gene accessibility activate neural-like progenitor (NRP) and tuft lineage enhancers, whereas basal committed tumors display esophageal transdifferentiation. Compared to SIP, classical-NRP and basal committed tumors have poorer outcomes, and show distinct PD-1/PD-L1 immune proteomic phenotypes and prognostic myofibroblast epigenetic states, respectively. Our work reveals links between lineage reprogramming, EMT, and epigenetic progression in human PDAC.

cancer biology↗

Tissue resident CD4+ memory T-cells mark response to immune checkpoint inhibition in high-grade glioma

Background: Immune checkpoint inhibitors (ICI) are efficacious in many solid tumors, but response in glioma is restricted to a small subgroup. The determinants of response and resistance to ICI remain poorly understood. Methods: Here we exploit a syngeneic hypermutated high-grade glioma model with dichotomous response to combined PD-1 and CTLA-4 inhibition to unravel determinants of tumor-infiltrating T-cells driving response. Tumor-infiltrating T-cells from ICI-responsive and non-responsive tumors were analyzed by single-cell RNA and T-cell receptor sequencing and tumor-reactive T-cell receptor clonotypes were functionally validated to characterize their transcriptional phenotypes. We verify our findings in IDH1 wildtype glioblastoma patients treated with neoadjuvant pembrolizumab. Results: ICI response was associated with intratumoral clonal expansion of tumor-reactive cytotoxic T-cells and increased infiltration of CXCR6+ CD4+ tissue resident memory T-cells (Trm). CD4 stem-like memory T-cells in responding tumors demonstrated elevated interferon responses, following trajectories toward clonally expanded Trm, versus trajectories toward exhaustion in non-responsive tumors. In responsive tumors, CD4+ Trm interacted with infiltrating CXCR3+ tumor-reactive and clonally expanded, yet transcriptionally versatile cytotoxic T-cells. Probing the post neoadjuvant ICI high-grade glioma patient tissue dataset, we confirmed increased CXCR6 expression in CD4+ T cells and the association of CD4+ Trm with prolonged overall survival. Conclusion: These findings identify CD4 tissue-resident memory T-cells as determinants of ICI response in IDH1 wildtype high-grade glioma and warrant their further investigation to improve immunotherapy outcomes.

cancer biology↗

Low-dose doxorubicin drives caveolin-1 depended re-epithelialization of breast cancer cells as a mechanism of cancer plasticity

Breast cancer progression is driven by dynamic changes in epithelial plasticity, membrane organization, and intracellular signaling, yet the effects of sustained low-dose chemotherapy on these processes remain poorly understood. Here, we investigated the impact of prolonged low-dose doxorubicin on membrane remodeling, epithelial phenotype, membrane-associated Ras lipid-anchor localization, and autophagy in mesenchymal-like MDA-MB-231 breast cancer cells. Low-dose doxorubicin significantly increased Caveolin-1 expression and enhanced E-cadherin protein levels, accompanied by a transition toward a more compact epithelial-like morphology with increased cell-cell contacts. Live-cell imaging demonstrated a significant reduction in the membrane-to-cytoplasm fluorescence ratio of the lipid-anchored GFP-tH probe, indicating redistribution from the plasma membrane to the cytoplasm following treatment. Analysis of autophagy-related proteins revealed decreased LC3-I together with increased LC3-II, ATG5, and p62 expression, consistent with autophagosome accumulation and impaired autophagic flux. Collectively, our findings demonstrate that low-dose doxorubicin promotes extensive remodeling of plasma membrane organization, epithelial plasticity, membrane-associated lipid-anchor localization, and autophagy. This integrated response reveals previously unrecognized links between membrane architecture, Ras membrane association, and autophagy during phenotypic reprogramming of breast cancer cells, providing mechanistic insight into cellular adaptations elicited by sub-cytotoxic doxorubicin exposure.

cancer biology↗